Press

Maiwald in the press

Royalty Pharma announces R&D Funding Collaboration with Merck

Novel collaboration structure supports pipeline innovation NEW YORK, NY, October 12, 2022 - Royalty Pharma plc (Nasdaq: RPRX) today announced that it has entered into an agreemen...

Dissatisfied industry users push back against EPO quality measures

For years, the patent community has debated the level of quality of the patents granted by the EPO. Although the office is making continual efforts to improve, its new Patent Quality Charter has been met with resistance – according to the industry, the EPO's renewed measur...

ECJ ruling brings clarity on the interruption of forfeiture periods

Susanna Heurung October 10, 2022 Susanna Heurung of Maiwald examines a decision by the European Cou...

Law firm will in future operate as Maiwald GmbH

Munich, 11 October 2022 - Maiwald, one of Germany's largest and most renowned law firms in the field of intellectual property, will in future operate under a new name: Effective October 11, 2022, Maiwald Patentanwaltsgesellschaft und Rechtsanwaltsgesellschaft mbH changed its...

Maiwald offers part of its office space to Munich volunteer organisation as a coordination hub for Ukrainian refugees

The patent attorneys’ firm of Maiwald has put part of its Munich office space at the disposal of the organisation “Münchner Freiwillige – Wir helfen e.V.” to use as a contact point for refugees fleeing Ukraine. From rooms in Elisenhof, located very close to...

Press Contact

Dr Eva Dörner

Partnerin

Patentanwältin

European Patent Attorney

Diplom-Chemikerin